Drugs for Klebsiella Pneumonia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 37)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Tazobactam |
Approved |
Phase 4 |
|
89786-04-9 |
123630 |
Synonyms:
(2S,3S,5S)-3-Methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide
(2S,3S,5S)-3-Methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide
CL-298741
Taszobactam sodium
TAZOBACTAM
Tazobactam sodium
|
Tazobactamum
YTR 830
YTR 830H
YTR-830
YTR-830H
|
|
2 |
|
Piperacillin |
Approved |
Phase 4 |
|
66258-76-2 |
43672 |
Synonyms:
(2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
AB piperacillin
AB-piperacillin
AHP brand OF piperacillin sodium
Astrapin brand OF piperacillin sodium
Curasan brand OF piperacillin sodium
Curasan, piperacillin
Fresenius brand OF piperacillin sodium
Hexal brand OF piperacillin sodium
Lederle brand OF pipracillin sodium
Monosodium salt, piperacillin
Peracin
PIPC
Pipcil
Pipera hameln
Piperacilina
Piperacillin
Piperacillin anhydrous
Piperacillin curasan
|
Piperacillin fresenius
Piperacillin hexal
PIPERACILLIN HYDRATE
Piperacillin monosodium salt
Piperacillin ratiopharm
Piperacillin sodium
Piperacillina
PIPERACILLINE
Pipéracilline
Piperacillin-ratiopharm
Piperacillinum
Pipera-hameln
Pipercillin
Pipracil
Pipril
Ratiopharm brand OF piperacillin sodium
Salt, piperacillin monosodium
Sodium, piperacillin
Wyeth brand OF piperacillin sodium
|
|
3 |
|
Meropenem |
Approved, Investigational |
Phase 4 |
|
119478-56-7, 96036-03-2 |
441130 |
Synonyms:
(1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylate
(1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylIC ACID
(2S,3R,4R)-2-[(1S,2R)-1-CARBOXY-2-HYDROXYPROPYL]-4-{[(3S,5R)-5-(DIMETHYLCARBAMOYL)PYRROLIDIN-3-YL]SULFANYL}-3-METHYL-3,4-DIHYDRO-2H-PYRROLE-5-CARBOXYLIC ACID
(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
Antibiotic SM 7338
ICI-194660
MEPM
Meronem
MEROPENEM
Meropenem anhydrous
|
MEROPENEM HYDRATE
MEROPENEM TRIHYDRATE
Meropenemum
MEROPENEMUM TRIHYDRICUM
Merrem
Merrem i.v.
MERREM IV
Penem
Ronem
SM-7338
ZD3591
|
|
4 |
|
Polymyxin B |
Approved, Vet_approved |
Phase 4 |
|
1405-20-5, 1404-26-8 |
4868 |
Synonyms:
Aerosporin
Aerosporin®
N-[3-Amino-1-({1-[(3-amino-1-{[6,9,18-tris(2-aminoethyl)-15-benzyl-2,5,8,11,14,17,20-heptahydroxy-3-(1-hydroxyethyl)-12-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclotricosa-1,4,7,10,13,16,19-heptaen-21-yl]-C-hydroxycarbonimidoyl}propyl)-C-hydroxycarbonimidoyl]-2-hydroxypropyl}-C-hydroxycarbonimidoyl)propyl]-6-methyloctanimidate
Polimixina B
Polymixin b sulfate
Polymixin b sulphate
Polymyxin b
Polymyxin b sulfate
|
Polymyxin b sulfate salt
Polymyxin b sulfuric acid
Polymyxin b sulphate
Polymyxin b sulphate salt
Polymyxin b sulphuric acid
Polymyxine B
Polymyxinum B
Sulfate, polymyxin b
|
|
5 |
|
Colistin |
Approved |
Phase 4 |
|
1264-72-8, 1066-17-7 |
5311054 |
Synonyms:
Colimycin
Colisticin
Colistin
Colistin sulfate
Colistina
Colistine
Colistinum
|
Coly-mycin
Kolimycin
N-[(1S)-3-Amino-1-{[(1S,2R)-1-{[(1S)-3-amino-1-{[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-2,5,8,11,14,17,20-heptahydroxy-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclotricosa-1,4,7,10,13,16,19-heptaen-21-yl]-C-hydroxycarbonimidoyl}propyl]-C-hydroxycarbonimidoyl}-2-hydroxypropyl]-C-hydroxycarbonimidoyl}propyl]-5-methylheptanimidate
Polymyxin e
Sulfate, colistin
Totazina
|
|
6 |
|
Tigecycline |
Approved |
Phase 4 |
|
220620-09-7 |
5282044 |
Synonyms:
(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
ABBR TGC
GAR 936
GAR-936
GAR-936,tigecycline
|
Tigeciclina
Tigecycline
Tigecyclinum
Tygacil
WAY-gar-936
|
|
7 |
|
Ertapenem |
Approved, Investigational |
Phase 4 |
|
153832-46-3 |
150610 |
Synonyms:
(1R,5S,6S,8R,2's,4's)-2-(2-(3-Carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylate
(1R,5S,6S,8R,2's,4's)-2-(2-(3-Carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid
(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate
(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid
|
Ertapenem
Ertapenem sodium
Invanoz
Invanz
|
|
8 |
|
Ciprofloxacin |
Approved, Investigational |
Phase 4 |
|
85721-33-1, 93107-08-5 |
2764 |
Synonyms:
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylate
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylate
1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylate
1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylate
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid
1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylIC ACID
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylate
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylate
1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylate
1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
Anhydrous, ciprofloxacin hydrochloride
Bacquinor
BAY O 9867 FREE BASE
Baycip
BAY-O-9867 FREE BASE
BAYQ3939
BAY-Q-3939
Bernoflox
CETRAXAL
Ciflox
Cifloxin
CILOXAN
Ciprinol
Cipro
Cipro I.V.
Cipro XL
Cipro XR
CIPROBAY
|
Ciprocinol
Ciprodar
Ciprofloxacin
Ciprofloxacin dihydrochloride
Ciprofloxacin HCl
Ciprofloxacin hydrochloride
Ciprofloxacin hydrochloride anhydrous
Ciprofloxacin monohydrochloride
Ciprofloxacin monohydrochloride monohydrate
Ciprofloxacina
Ciprofloxacine
Ciprofloxacino
Ciprofloxacinum
Cipromycin
Ciproquinol
Ciproxan
Ciproxin
CPFX
CPR867
Flociprin
Floxin
Hydrochloride anhydrous, ciprofloxacin
Hydrochloride, ciprofloxacin
Monohydrate, ciprofloxacin monohydrochloride
Monohydrochloride monohydrate, ciprofloxacin
Ocuflox
OTIPRIO
Proquin XR
Septicide
VELMONIT
Velomonit
|
|
9 |
|
Ceftriaxone |
Approved |
Phase 4 |
|
73384-59-5 |
5479530 |
Synonyms:
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulphanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulphanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Anhydrous ceftriaxone sodium
Benaxona
Biotrakson
Boehringer mannheim brand OF ceftriaxone sodium
C18H18N8O7S3
Cefatriaxone
Cefaxona
Ceftrex
Ceftriaxon
Ceftriaxon curamed
Ceftriaxon hexal
Ceftriaxona
Ceftriaxona [INN-Spanish]
Ceftriaxona andreu
Ceftriaxona LDP torlan
CEFTRIAXONE
Ceftriaxone irex
Ceftriaxone sodium
Ceftriaxone sodium, anhydrous
Ceftriaxone, disodium salt
Ceftriaxone, disodium salt, hemiheptahydrate
Ceftriaxonum
|
Ceftriaxonum [INN-Latin]
Ceftriazone
Columbia brand OF ceftriaxone
CTRX
Curamed brand OF ceftriaxone sodium
FIDATO
Fustery brand OF ceftriaxone sodium
Galen brand OF ceftriaxone sodium
Hexal brand OF ceftriaxone sodium
Hoffman la roche brand OF ceftriaxone sodium
Hoffman-la roche brand OF ceftriaxone sodium
Inibsa brand OF ceftriaxone sodium
Irex brand OF ceftriaxone
Lendacin
Longacef
Longaceph
Pisa brand OF ceftriaxone sodium
Rocefalin
Rocefin
Rocephin
Rocephine
Roche brand OF ceftriaxone sodium
Sodium, ceftriaxone
Syntex brand OF ceftriaxone sodium
Tacex
Terbac
|
|
10 |
|
Levoleucovorin |
Approved, Experimental, Investigational |
Phase 4 |
|
68538-85-2, 58-05-9, 73951-54-9 |
149436 6006 |
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R)-Leucovorin
(6R,2'S)-Folinic acid
(6R,S)-5-Formyltetrahydrofolate
(6S)-5-Formyl-5,6,7,8-tetrahydrofolate
(6S)-5-FORMYL-5,6,7,8-TETRAHYDROFOLIC ACID
(6S)-5-Formyltetrahydrofolate
(6S)-5-FORMYLTETRAHYDROFOLIC ACID
(6S)-Folinate
(6S)-FOLINIC ACID
(6S)-LEUCOVORIN
(S)-LEUCOVORIN
[6R]-5-formyl-5,6,7,8-tetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formlyl-5,6,7,8-tetrahydrofolate,calcium salt
5-Formyl-(6S)-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formylTHF
6 S Leucovorin
6R-Leucovorin
6S Leucovorin
6S-Leucovorin
6-S-Leucovorin
Acid, folinic
Acide folinique
Acido folinico
ácido levofolínico
Calcium citrovorum factor
Calcium folinate
Calcium leucovorin
CF
Citrovorum factor
Dextrofolinic acid
Factor, citrovorum
Folinate
Folinate, calcium
Folinic acid
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid SF
Folinic acid-SF
FUSILEV
KHAPZORY
|
Kunyrin
L(-)-5-Formyl-5,6,7,8-tetrahydrofolate
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
Leucal
Leucoverin
Leucovorin
Leucovorin calcium
Leucovorin folinic acid
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, (S)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, (S)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monopotassium salt, (S)-isomer
Leucovorin, monosodium salt
Leucovorin, monosodium salt, (S)-isomer
Leucovorinum
Leukovorin
Leukovorum
Levo leucovorin
LEVOFOLENE
Levofolinate
LEVOFOLINIC ACID
Levoleucovorin
Levo-leucovorin
L-Folinate
L-FOLINIC ACID
LFP-754
L-Leucovorin
L-N-[P-[[(2-amino-5-Formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamate
N-[4-({[(6S)-2-AMINO-5-FORMYL-4-OXO-1,4,5,6,7,8-HEXAHYDROPTERIDIN-6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID
N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
N5-Formyl-THF
Pteroyl-D-glutamate
Rescuvolin
S Leucovorin
S-Leucovorin
Welcovorin
Wellcovorin
|
|
11 |
|
Trimethoprim |
Approved, Vet_approved |
Phase 4 |
|
738-70-5 |
5578 |
Synonyms:
2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine
5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine
BW-5672
BW-56-72
CO-Trimoxazole
IPRAL
LEDATRIM
MONOTRIM
NIH-204
NSC-106568
POLYTRIM
PRIMSOL
Proloprim
PROLOPRIN
|
SYRAPRIM
TCMDC-125538
TIEMPE
TMP
TRIMETHOPRIM
TRIMETHOPRIME
TRIMÉTHOPRIME
TRIMETHOPRIMUM
TRIMETOPRIMA
TRIMOGAL
TRIMOPAN
Trimpex
TRIMPEX 200
TRIPRIMIX 200
|
|
12 |
|
Sulfamethoxazole |
Approved |
Phase 4 |
|
723-46-6 |
5329 |
Synonyms:
3-(p-Aminobenzenesulfonamido)-5-methylisoxazole
3-(p-Aminophenylsulfonamido)-5-methylisoxazole
3-(p-Aminophenylsulphonamido)-5-methylisoxazole
3-(Para-aminophenylsulphonamido)-5-methylisoxazole
3-Sulfanilamido-5-methylisoxazole
3-Sulphanilamido-5-methylisoxazole
4-Amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulphonamide
5-Methyl-3-sulfanilamidoisoxazole
5-Methyl-3-sulfanylamidoisoxazole
5-Methyl-3-sulfonylamidoisoxazole
5-Methyl-3-sulphanil-amidoisoxazole
ACETYLSULFAMETHOXAZOLE
Apo-Sulfamethoxazole
Azo Gantanol
Azo-gantanol
Bactrim
Bactrimel
Gamazole
Gantanol
GANTANOL (TN)
GANTANOL-DS
Metoxal
N'-(5-methyl-3-isoxazole)sulfanilamide
N'-(5-methyl-3-isoxazolyl)sulfanilamide
N'-(5-methyl-3-isoxazolyl)-sulfanilamide
N'-(5-methylisoxazol-3-yl)sulphanilamide
N^1-(5-methyl-3-isoxazolyl)-sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulfanilamide
N1-(5-Methyl-3-isoxazolyl)-sulfanilamide
|
N1-(5-Methyl-3-isoxazolyl)sulphanilamide
Ndimethyl1-(5-methyl-3-isoxazolyl)-sulfanilamide
NSC-147832
Radonil
RO-42130
RO-4-2130
Septran
SIM
Simsinomin
Sinomin
SMX
SMZ
STX-608
Sulfamethalazole
Sulfamethoxazol
SULFAMETHOXAZOLE
SULFAMETHOXAZOLE SODIUM
Sulfamethoxazole(usan)
Sulfamethoxizole
Sulfamethylisoxazole
Sulfametoxazol
Sulfisomezole
Sulphamethalazole
Sulphamethoxazol
Sulphamethoxazole
Sulphamethoxazole BP 98
Sulpha-methoxizole
Sulphamethylisoxazole
Sulphisomezole
SUPHAMETHOXAZOLE
Trib
UROBAK
|
|
13 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
59-30-3 |
6037 |
Synonyms:
(2S)-2-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)FORMAMIDO]PENTANEDIOIC ACID
(2S)-2-[[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]-OXO-METHYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]GLUTARIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC ACID
[<sup>3</sup>H]-folic acid
Acide folique
ácido fólico
Acidum folicum
ACIFOLIC
Apo-Folic
B03BB01
b9, Vitamin
BIO SCIENCE
CYTOFOL
DOSFOLAT B ACTIV
FOLACID
FOLACIN
FOLATE
FOLBAL
FOLCIDIN
FOLDINE
FOLETTES
FOLIAMIN
FOLIC ACID
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
FOLICARE
FOLICET
FOLIPAC
|
FOLSAEURE
FOLSAN
FOLSAURE
Folsäure
FOLSAV
FOLVITE
Folvron
INCAFOLIC
LEXPEC
LIVER LACTOBACILLUS CASEI FACTOR
MILLAFOL
N-(4-{[(2-AMINO-4-OXO-3,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)-L-GLUTAMIC ACID
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)CARBONYL]-L-GLUTAMIC ACID
N-[4-[[(2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL]AMINO]BENZOYL]-L-GLUTAMIC ACID
NATUR FLOW
N-Pteroyl-L-glutamate
N-PTEROYL-L-GLUTAMIC ACID
NSC-3073
PGA
PRECONCEIVE
PTEGLU
PTEROYLGLUTAMATE
PTEROYLGLUTAMIC ACID
PTEROYL-L-GLUTAMATE
PTEROYL-L-GLUTAMIC ACID
PTEROYL-L-MONOGLUTAMATE
PTEROYL-L-MONOGLUTAMIC ACID
PTEROYLMONOGLUTAMIC ACID
ROCHE
Vitamin B9
VITAMIN BC
VITAMIN BE
VITAMIN M
|
|
14 |
|
beta-Lactamase Inhibitors |
|
Phase 4 |
|
|
|
15 |
|
Piperacillin, Tazobactam Drug Combination |
|
Phase 4 |
|
|
|
16 |
|
Pharmaceutical Solutions |
|
Phase 4 |
|
|
|
17 |
|
Polymyxins |
|
Phase 4 |
|
|
|
18 |
|
Gentamicins |
|
Phase 4 |
|
|
|
19 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
20 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
21 |
|
Antibiotics, Antitubercular |
|
Phase 4 |
|
|
|
22 |
|
Folic Acid Antagonists |
|
Phase 4 |
|
|
|
23 |
|
Folate |
|
Phase 4 |
|
|
|
24 |
|
Liver Extracts |
|
Phase 4 |
|
|
|
25 |
|
Vitamin B9 |
|
Phase 4 |
|
|
|
26 |
|
Antiprotozoal Agents |
|
Phase 4 |
|
|
|
27 |
|
Antiparasitic Agents |
|
Phase 4 |
|
|
|
28 |
|
Vitamin B Complex |
|
Phase 4 |
|
|
|
29 |
|
Antimalarials |
|
Phase 4 |
|
|
|
30 |
|
Trimethoprim, Sulfamethoxazole Drug Combination |
|
Phase 4 |
|
|
|
31 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 4 |
|
|
|
32 |
|
Sitafloxacin |
Experimental, Investigational |
Phase 2, Phase 3 |
|
163253-35-8 |
|
Synonyms:
|
33 |
|
Vaccines |
|
Phase 1, Phase 2 |
|
|
|
34 |
|
Imipenem |
Approved |
|
|
74431-23-5, 64221-86-9 |
104838 |
Synonyms:
(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylate
(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate
(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5R,6S)-3-(2-Formimidoylamino-ethylsulphanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate
(5R,6S)-3-(2-Formimidoylamino-ethylsulphanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure
Anhydrous imipenem
Anhydrous, imipenem
Imipemide
IMIPENEM
|
Imipenem anhydrous
Imipenem, anhydrous
Imipenem, N-formimidoyl thienamycin
Imipenemum
IMP
IPM
MK-0787
N Formimidoylthienamycin
N-Formimidoyl thienamycin
N-Formimidoylthienamycin
|
|
35 |
|
Vancomycin |
Approved |
|
|
1404-90-6 |
14969 |
Synonyms:
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-a-L-lyxo-hexopyranosyl)-b-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylate
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-a-L-lyxo-hexopyranosyl)-b-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylate
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylate
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(2.2SP,3.5SA,2.6SP)-O(4.2),C(3.4)
(2.2Sp,3.5Sa,2.6Sp)-O(4.2),C(3.4):C(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
(2.2Sp,3.5Sa,2.6Sp)-O(4.2),C(3.4):C(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-b-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-a-L-lyxo-hexopyranosyl)-b-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-b-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
(2.2Sp,3.5Sa,2.6Sp)-O(4.2),C(3.4):C(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-β-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-β-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
Abbott brand OF vancomycin hydrochloride
AB-vancomycin
Azupharma brand OF vancomycin hydrochloride
C(5.4),O(4.6)
Cell pharm brand OF vancomycin hydrochloride
Chiesi brand OF vancomycin hydrochloride
Combino brand OF vancomycin hydrochloride
Curasan brand OF vancomycin hydrochloride
Dakota brand OF vancomycin hydrochloride
Diatracin
Dista brand OF vancomycin hydrochloride
Eli lilly brand OF vancomycin hydrochloride
Hexal brand OF vancomycin hydrochloride
Hydrochloride, vancomycin
Lilly brand OF vancomycin hydrochloride
MIP brand OF vancomycin hydrochloride
Norman brand OF vancomycin hydrochloride
Ratiopharm brand OF vancomycin hydrochloride
|
Sulfate, vancomycin
Vanco azupharma
Vanco-cell
Vancocin
Vancocin HCL
Vancocine
VANCOLED
Vancomicin
Vancomicina
Vancomicina abbott
Vancomicina chiesi
Vancomicina combino phar
Vancomicina norman
VANCOMYCIN
Vancomycin HCL
Vancomycin hexal
Vancomycin hydrochloride
Vancomycin lilly
Vancomycin phosphate (1:2)
Vancomycin phosphate (1:2), decahydrate
Vancomycin sulfate
Vancomycine
Vancomycine dakota
Vancomycin-ratiopharm
Vancomycinum
VANCOR
Vanco-saar
|
|
36 |
|
Framycetin |
Approved, Experimental, Vet_approved |
|
|
1404-04-2, 119-04-0, 3947-65-7 |
413349 8378 |
Synonyms:
2-desoxy-4-O-(2,6-diamino-2,6-didesoxy-α-D-glucopyranosyl)-D-streptamin
4-O-(2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl)-2-deoxy-D-streptamine
Antibiotic 10676
ANTIBIOTIQUE EF 185
Biosol
Bykomycin
Caswell no. 595
Dekamycin V
Endomixin
Fradiomycin
Fradiomycin b
Fradiomycin sulfate
Framicetina
Framycetin
Framycetin sulfate
Framycetine
Framycétine
Framycetinum
Fraquinol
FRM
Kaomycine
Lidamycin Creme
Myacine
Myacyne
Mycifradin
Mycifradin-N
Myciguent
NEAMINE
Nebramycin X
Negamicin
|
Neobiotic
Neobrettin
Neofracin
Neo-Fradin
Neolate
Neo-Mantle Creme
Neomicina
Neomix
NEOMYCIN
Neomycin A
Neomycin b
Neomycin b sulfate
Neomycin palmitate
Neomycin sulfate
Neomycin sulphate
Neomycin trisulfate salt hydrate
NEO-RX
Neo-Rx®|neomycin sulfate
Neosulf
Nivemycin
Palmitate, neomycin
Soframycin
Sulfate, fradiomycin
Sulfate, framycetin
Sulfate, neomycin
Sulfate, neomycin b
Tuttomycin
USAF CB-19
Vonamycin
Vonamycin Powder V
|
|
37 |
|
Streptomycin |
Approved, Vet_approved |
|
|
57-92-1 |
19649 |
Synonyms:
[2-Deoxy-2-(dimethylamino)-a-L-glucopyranosyl]-(1->2)-[5-deoxy-3-C-formyl-a-L-lyxofuranosyl]-(1->4)-{n',n'''-[(1,3,5/2,4,6)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl]diguanidine}
[2-Deoxy-2-(dimethylamino)-alpha-L-glucopyranosyl]-(1->2)-[5-deoxy-3-C-formyl-alpha-L-lyxofuranosyl]-(1->4)-{n',n'''-[(1,3,5/2,4,6)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl]diguanidine}
[2-Deoxy-2-(dimethylamino)-α-L-glucopyranosyl]-(1->2)-[5-deoxy-3-C-formyl-α-L-lyxofuranosyl]-(1->4)-{n',n'''-[(1,3,5/2,4,6)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl]diguanidine}
2,4-Diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-O-(2-deoxy-2-methylamino-a-L-glucopyranosyl)-3-C-formyl-b-L-lyxopentanofuranoside
2,4-Diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-O-(2-deoxy-2-methylamino-alpha-L-glucopyranosyl)-3-C-formyl-beta-L-lyxopentanofuranoside
2,4-Diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-O-(2-deoxy-2-methylamino-α-L-glucopyranosyl)-3-C-formyl-β-L-lyxopentanofuranoside
CEPA brand OF streptomycin sulfate
CHEMFORM
Clariana brand OF streptomycin sulfate
ESTREPTOMICINA
Estreptomicina cepa
Estreptomicina clariana
Estreptomicina normon
Fatol brand OF streptomycin sulfate
GEROX
Grünenthal brand OF streptomycin sulfate
Kantrex
Normon brand OF streptomycin sulfate
NSC-14083
Panpharma brand OF streptomycin sulfate
Sanavita brand OF streptomycin sulfate
|
SM
Streomycin
STREPCEN
Strepto fatol
Strepto hefa
Strepto-fatol
Strepto-hefa
STREPTOMICINA
STREPTOMYCIN
Streptomycin a sulfate
Streptomycin grünenthal
Streptomycin sesquisulfate hydrate
Streptomycin sesquisulphate hydrate
Streptomycin sulfate
Streptomycin sulfate (2:3) salt
Streptomycin sulphate
Streptomycin, sulfate salt
Streptomycine panpharma
STREPTOMYZIN
Wernigerode brand OF streptomycin sulfate
|
|
Interventional clinical trials:
(show all 27)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic Urinary Tract Infections Due to Extended-spectrum β-lactamase (ESBL)-Producing Escherichia Coli or Klebsiella Pneumoniae - (CAPITIS Study) |
Unknown status |
NCT03891433 |
Phase 4 |
Meropenem;Ertapenem 1000 MG;Piperacillin, Tazobactam 4-0.5G Solution for Injection |
2 |
Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae |
Unknown status |
NCT04489459 |
Phase 4 |
Colistin;Meropenem;Tigecycline |
3 |
SELECTIVE DIGESTIVE DECONTAMINATION USING ORAL GENTAMICIN AND ORAL POLYMYXIN E FOR ERADICATION OF CARBAPENEM-RESISTANT KLEBSIELLA PNEUMONIAE CARRIAGE IN HOSPITALIZED PATIENTS |
Unknown status |
NCT01761487 |
Phase 4 |
|
4 |
A Multi-centre Randomised Open-label Active Comparator-controlled Non-inferiority Trial Comparing Oral to Intravenous Antibiotics in the Early Management of Klebsiella Pneumoniae Liver Abscess |
Completed |
NCT01723150 |
Phase 4 |
Ciprofloxacin;Ceftriaxone;Trimethoprim/sulfamethoxazole;Ertapenem |
5 |
Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients |
Recruiting |
NCT02729116 |
Phase 2, Phase 3 |
Sitafloxacin;Ertapenem |
6 |
Safety and Efficacy Study of Eradication of Carbapenem Resistant Klebsiella Pneumonia From the Gastrointestinal Tract by Probiotics. |
Unknown status |
NCT00722410 |
Phase 1, Phase 2 |
Polyethylene glycol |
7 |
Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V) Administered to Healthy Adults: A FTIH Phase I/II Randomized and Controlled Study |
Completed |
NCT04959344 |
Phase 1, Phase 2 |
|
8 |
Randomized, Superiority, Double Blind Controlled With Placebo, Clinical Trial, to Demonstrate the Effectiveness of Fecal Microbiota Transplantation for Selective Intestinal Decolonization of Patients Colonized by Klebsiella Pneumoniae Carbapenemase (KPC)-Producing |
Recruiting |
NCT04760665 |
Phase 2 |
|
9 |
Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae. |
Unknown status |
NCT04337840 |
|
|
10 |
Comparison of Clinical Outcomes in Bloodstream Infections With Carbapenem Hetero-resistant vs Carbapenem Resistant Klebsiella Pneumoniae (COMBAT) |
Unknown status |
NCT04229498 |
|
Monotherapy and combination therapy (all antibiotics that are given by attending pysicians and can be active against Klebsiella pneumoniae will be evaluated) |
11 |
Klebsiella Pneumoniae Infection in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome |
Unknown status |
NCT03598543 |
|
|
12 |
WGS-guided Tracking and Infection Control Measures of Carbapenem-resistant Klebsiella Pneumoniae |
Unknown status |
NCT04413305 |
|
|
13 |
Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China |
Unknown status |
NCT03245632 |
|
|
14 |
Effects of Piperacillin-Tazobactam Use on the Prevalence Rate of Extended-Spectrum Beta-Lactamase (ESBL) Producing Escherichia Coli and Klebsiella Pneumoniae in Hematology and Oncology Units. |
Completed |
NCT00167999 |
|
piperacillin-tazobactam |
15 |
Antibiotic Intervention Trial in a Medical Intensive Care Unit to Reduce the Acquisition of Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae. |
Completed |
NCT00167986 |
|
vancomycin-resistant enterococci and ESBL |
16 |
Community - Associated Extended-spectrum Beta-lactamases (ESBL) |
Completed |
NCT00363220 |
|
|
17 |
Efficacy of Intestinal Decontamination in Patients Colonized by Carbapenem-resistant Klebsiella Pneumoniae and Colistin |
Completed |
NCT02604849 |
|
Neomycin;Streptomycin;Gentamicins |
18 |
Risk Factors for Quinolone Resistance Among Extended-Spectrum Beta-Lactamase-Producing Klebsiella Species |
Completed |
NCT00518661 |
|
|
19 |
Double Carbapenem as Rescue Strategy for the Treatment of Severe Carbapenemase-Producing Klebsiella Pneumoniae Infections: A Two-Center Matched Case-Control Study |
Completed |
NCT03094494 |
|
|
20 |
Turkish Prospective Cohort Study on Carbapenem Resistant Klebsiella Pneumonia Bacteremia: a National Multicenter Observational Study |
Completed |
NCT03597841 |
|
Combination therapy |
21 |
Klebsiella Pneumoniae Necrotizing Fasciitis: Clinical and Microbiological Features |
Completed |
NCT01139112 |
|
|
22 |
A Randomized Open Label Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC). |
Completed |
NCT01266499 |
|
Colistin (Polymyxin E) 100mg x 4/d;both medications;will not receive PO treatment;PO Garamycin 80mg x 4/d |
23 |
Sites of Colonization in Hospitalized Patients With Infections Caused by Extended-Spectrum Beta-Lactamase Producing Escherichia Coli and Klebsiella Pneumoniae |
Completed |
NCT01324726 |
|
|
24 |
Antimicrobial Resistance Rate In Escherichia Coli And Klebsiella Pneumonia : A Retrospective Study |
Completed |
NCT04196387 |
|
|
25 |
The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy |
Completed |
NCT01612182 |
|
|
26 |
Type VI Secretion System in Klebsiella Pneumoniae Relation to Antibiotic Resistance and Biofilm Formation |
Recruiting |
NCT05516654 |
|
|
27 |
Prognosis of Klebsiella ESBL Sepsis: Role of 2-HYDRoxy-myristate in Endotoxin Structure |
Active, not recruiting |
NCT05193045 |
|
|
|